CHICAGO – A technology platform developed by Georgetown University Medical Center researchers and collaborators from cancer centers nationwide has dramatically cut turnaround time for assessing patient suitability for clinical trials and boosted the historically low trial enrollment rate for adults with pancreatic cancer.
Get the full story with
Premium Access
Only $95 for the
first 90 days*
Premium Access gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try Premium Access now.
You may already have institutional access!
Check if I qualify.
Already a Precision Oncology News or 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.